Natural product therapy for pulmonary arterial hypertension: Scutellaria baicalensis inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3

A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November 2009 issue of the journal “Nature Medicine”[the number 1 journal in General Medicine with an I.F of 28.054] by Prof. Thistlethwaite PA, Li X and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product therapy for pulmonary arterial hypertension: Scutellaria baicalensis inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3

Significance:

Scutellaria baicalensis, by increasing the expression of its target gene, it may decrease the expression of Notch3. Thus, pharmacological formulations encompassing “Scutellaria baicalensis or an active compound isolated from it” may be used to treat pulmonary arterial hypertension.

Undisclosed information: How Scutellaria baicalensis decreases the expression of Notch3

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org or http://newbioideas.com

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, Natural product therapy for pulmonary arterial hypertension: Scutellaria baicalensis inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 26/September/2016, 9.54 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Amount: $150

Satisfaction-guaranteed-if-not-refunded

# Research cooperation